SS-31

For Research Use Only

Injectable

SS-31 is engineered to target the mitochondria directly, binding a molecule called cardiolipin found only in the mitochondria's inner membrane to help preserve their structure and energy-producing efficiency. Its mitochondrial mechanism is well-enough established that its pharmaceutical version recently became the first-ever FDA-approved therapy for a mitochondrial disease. That approval — for a specific rare condition rather than general wellness use — reflects just how thoroughly this peptide's core mechanism has been validated in human biology. Commonly used for: mitochondrial energy and resilience, especially for performance- or aging-focused clients

This product is not for human or animal consumption. Misuse of this product is illegal.